Pfizer climbs 4% on 2025 outlook
Evan David Seigerman, BMO analyst, joins ‘Closing Bell Overtime’ to talk Pfizer’s 2025 outlook.
Source link
Evan David Seigerman, BMO analyst, joins ‘Closing Bell Overtime’ to talk Pfizer’s 2025 outlook.
Source link
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Sen. Marsha Blackburn (R-Tenn.) and Sen. Richard Blumenthal (D-Conn.) join ‘Squawk Box’ to discuss the fate of the Kids Online Safety Act, the challenges facing the bill, how likely it will get passed in the House, and more. Source link
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Ray Wang, Constellation Research founder, chairman and principal analyst, joins ‘Squawk Box’ to discuss the decline in Nvidia’s stock price post-earnings, Wang’s investment thesis on the stock, and much more. Source link
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Barton Crockett, Rosenblatt analyst, joins ‘Squawk on the Street’ to discuss Apple and Amazon’s ‘buy’ rating at Rosenblatt, if Amazon’s e-commerce business still matters for the company, and much more. 04:05 Fri, Nov 29 202410:34 AM EST Source link
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Nicholas Campanella, Barclays analyst, joins ‘Squawk on the Street’ to discuss the timeline to expect nuclear power to come online to support data centers, the small modular reactor technology, and if investors should still buy utility stocks given the run up. Source…
The final trades of the day with CNBC’s Melissa Lee and the Fast Money traders. Source link
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Nela Richardson, chief economist at ADP, discusses employment in the U.S. and explains how President-elect Donald Trump will impact the U.S. labour market. Source link